Author:
Aoki T,Shimada K,Suzuki R,Izutsu K,Tomita A,Maeda Y,Takizawa J,Mitani K,Igarashi T,Sakai K,Miyazaki K,Mihara K,Ohmachi K,Nakamura N,Takasaki H,Kiyoi H,Nakamura S,Kinoshita T,Ogura M
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2008.
2. Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003; 102: 3871–3879.
3. Zinzani PL, Stefoni V, Finolezzi E, Brusamolino E, Cabras MG, Chiappella A et al. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study. Clin Lymphoma Myeloma 2009; 9: 381–385.
4. Rieger M, Osterborg A, Pettengell R, White D, Gill D, Walewski J et al. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. Ann Oncol 2011; 22: 664–670.
5. Savage KJ, Yenson PR, Shenkier T, Klasa R, Villa D, Goktepe O et al. The outcome of primary mediastinal large b-cell lymphoma (PMBCL) in the R-CHOP treatment era. ASH Annu Meet Abstr 2012; 120: 303.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献